Загрузка...
Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its potential implications for Parkinson disease
Gaucher disease, caused by pathological mutations GBA1, encodes the lysosome-resident enzyme glucocerebrosidase, which cleaves glucosylceramide into glucose and ceramide. In Gaucher disease, glucocerebrosidase deficiency leads to lysosomal accumulation of substrate, primarily in cells of the reticul...
Сохранить в:
| Опубликовано в: : | Expert Rev Proteomics |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381920/ https://ncbi.nlm.nih.gov/pubmed/27098312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14789450.2016.1174583 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|